1-5 of 5
Einat Galamidi-Cohen
Close
Sort by
Journal Articles

Hematopoietic Stem Cell Transplantation (HSCT) with Omidubicel Is Associated with Robust Immune Reconstitution and Lower Rates of Severe Infection Compared to Standard Umbilical Cord Blood Transplantation

Paul Szabolcs, Stuart Levy, Dima Yackoubov, Aviad Pato, Einat Galamidi-Cohen, Mitchell E. Horwitz
Journal: Blood
Blood (2021) 138 (Supplement 1): 333.
https://doi.org/10.1182/blood-2021-153408
Published: 2021
Journal Articles

Hospitalization and Healthcare Resource Use of Omidubicel Vs Cord Blood Transplantation for Hematological Malignancies in a Global Randomized Phase III Clinical Trial

Navneet S. Majhail, Beckley Miller, Rebecca Dean, Rocio Manghani, Smitha Sivaraman, Einat Galamidi-Cohen, Richard T. Maziarz
Journal: Blood
Blood (2021) 138 (Supplement 1): 4036.
https://doi.org/10.1182/blood-2021-147480
Published: 2021
Journal Articles

Allogeneic Stem Cell Transplantation with Omidubicel: Long-Term Follow-up from a Single Center

Chenyu Lin, Laura Morrison, Edwin P. Alyea, III, Taewoong Choi, Cristina Gasparetto, Gwynn D. Long, Richard D. Lopez, David A Rizzieri, Stefanie Sarantopoulos, Anthony D. Sung, Nelson J. Chao, Einat Galamidi-Cohen, Aurelie Schwarzbach, Mitchell E. Horwitz
Journal: Blood
Blood (2021) 138 (Supplement 1): 1827.
https://doi.org/10.1182/blood-2021-145535
Published: 2021
Journal Articles

Omidubicel vs standard myeloablative umbilical cord blood transplantation: results of a phase 3 randomized study

Clinical Trials & Observations
Mitchell E. Horwitz, Patrick J. Stiff, Corey Cutler, Claudio Brunstein, Rabi Hanna, Richard T. Maziarz, Andrew R. Rezvani, Nicole A. Karris, Joseph McGuirk, David Valcarcel, Gary J. Schiller, Caroline A. Lindemans, William Y. K. Hwang, Liang Piu Koh, Amy Keating, Yasser Khaled, Nelson Hamerschlak, Olga Frankfurt, Tony Peled, Irit Segalovich, Beth Blackwell, Stephen Wease, Laurence S. Freedman, Einat Galamidi-Cohen, Guillermo Sanz
Journal: Blood
Blood (2021) 138 (16): 1429–1440.
https://doi.org/10.1182/blood.2021011719
Published: 2021
Includes: Supplemental data
Journal Articles

StemEx®(Copper Chelation Based) Ex Vivo Expanded Umbilical Cord Blood Stem Cell Transplantation (UCBT) Accelerates Engraftment and Improves 100 Day Survival In Myeloablated Patients Compared To a Registry Cohort Undergoing Double Unit UCBT: Results Of a Multicenter Study Of 101 Patients With Hematologic Malignancies

Patrick J Stiff, MD, Pau Montesinos, Tony Peled, MSc, Efrat Landau, MSc, Noga Rosenheimer, PhD, Julie Mandel, MSc, Nira Hasson, BSc, Esti Olesinski, MSc, Ela Glukhman, MSc, David A. Snyder, PhD, Einat Galamidi Cohen, MD, Orna Srur Kidron, RN, MPA, Dalia Bracha, RN, MPA, Dorit Harati, BSc, Keren Ben-Abu, BSc, MBA, Etty Freind, RN, BA, Laurence Freedman, PhD, Yael C Cohen, MD, Liraz Olmer, MSc, Raya Barishev, Vanderson Rocha, MD, Mary M. Horowitz, MD, MS, Mary Eapen, MBBS, MS, Arnon Nagler, MD, MSc, Guillermo Sanz, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 295.
https://doi.org/10.1182/blood.V122.21.295.295
Published: 2013